Gurusamy, KS and Koti, R and Fusai, G and Davidson, BR (2012) Somatostatin analogues for pancreatic surgery. Cochrane Database Syst Rev , 6 CD008370 - ?. 10.1002/14651858.CD008370.pub2.
Full text not available from this repository.
Pancreatic resections are associated with high morbidity (30% to 60%) and mortality (5%). Synthetic analogues of somatostatin are advocated by some surgeons to reduce complications following pancreatic surgery, however their use is controversial.
|Title:||Somatostatin analogues for pancreatic surgery.|
|Keywords:||Gastrointestinal Agents, Humans, Length of Stay, Octreotide, Pancreas, Pancreatectomy, Pancreatic Diseases, Pancreatic Fistula, Pancreaticoduodenectomy, Postoperative Complications, Publication Bias, Randomized Controlled Trials as Topic, Sepsis, Somatostatin|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Surgery and Interventional Science (Division of) > Research Department of General Surgery|
Archive Staff Only: edit this record